Recomposition Option — Stacking Protocols
Visceral fat reduction with lean mass preservation
Overview
This protocol combines Tesamorelin + CJC-1295/Ipamorelin for visceral fat reduction with lean mass preservation. Originally from the Weight & Metabolism category.
Indications
- Visceral fat reduction with lean mass preservation
- Synergistic peptide combination therapy
- Multi-pathway optimization
Mechanism of Action
Visceral fat reduction with lean mass preservation
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Tesamorelin + CJC-1295/Ipamorelin | See dosing notes | As per protocol | Follow detailed dosing schedule below |
Evidence Grade
GRADE C
Safety & Contraindications
- Requires physician supervision for peptide stacking
- Monitor for additive or synergistic side effects
- Follow individual peptide safety guidelines for each component
- Use sterile technique for all injections
- Consult healthcare provider before combining multiple peptides